Marcus Schulz - 18 Apr 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Reporting relationship: Chief Revenue Officer
Issuer ticker: BLFS
Reported as of: 18 Apr 2022
Net transaction value: -$5,031
SEC form: 4
Accepted by SEC: 19 Apr 2022, 20:15:45 UTC
Prior SEC filing: 09 Mar 2022
Next SEC filing: 22 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Marcus Schulz

Key filing fact

Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 19 Apr 2022.

Key facts

This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Apr 2022, 20:15.

Change

Previous filing in this sequence was filed on 09 Mar 2022.
Current net transaction value: -$5,031.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLFS transaction

Common Stock

Sale

Transaction value: $5,031
Shares: -286
Change %: -0.68%
Price: $17.59
Shares after: 41,957
Date: 18 Apr 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59.